Bin Xu

机构：Qingdao University, Kunming University, Peking University, Kunming Medical University, The First People's Hospital of Changzhou, Affiliated Hospital of Qingdao University · ORCID：0000-0001-7998-9314

发表论文 274 篇 · 总被引 6398 次 · h-index 41

代表论文

Dual-targeted alpha therapy mitigates prostate cancer and boosts immune checkpoint blockade therapy (2025 · Journal of Controlled Release · 被引 6)
To investigate the tumor promotion role of PLOD3 in colorectal cancer and its potential as a prognostic biomarker and therapeutic target (2025 · Scientific Reports · 被引 6)
Quantum-Enhanced Dark Matter Search Using Cat States (2026 · Physical Review Letters · 被引 4)
Fibroblasts promote the progression of benign prostatic hyperplasia through colony-stimulating factor 1 receptor-mediated RTK signaling in prostatic epithelial cells (2025 · Molecular Biomedicine · 被引 4)
RGS14 promotes the progression of hepatocellular carcinoma by activating the cAMP/PKA/CREB signaling pathway (2025 · Journal of Cancer Research and Clinical Oncology · 被引 4)
Engineered extracellular vesicles as imaging biomarkers and therapeutic applications for urological diseases (2025 · Materials Today Bio · 被引 4)